These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 20869671
1. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases. Naba MR, Araj GF, Baban TA, Tabbarah ZA, Awar GN, Kanj SS. J Infect Public Health; 2010; 3(3):113-7. PubMed ID: 20869671 [Abstract] [Full Text] [Related]
2. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Jones RN, Fritsche TR, Sader HS. Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501 [Abstract] [Full Text] [Related]
3. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia. Endimiani A, Brigante G, Bettaccini AA, Luzzaro F, Grossi P, Toniolo AQ. BMC Infect Dis; 2005 Nov 24; 5():106. PubMed ID: 16307682 [Abstract] [Full Text] [Related]
4. Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Low DE. Clin Infect Dis; 2004 May 15; 38 Suppl 4():S357-62. PubMed ID: 15127370 [Abstract] [Full Text] [Related]
5. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, Mpembe R, Quan V, Whitelaw A, Hoffmann R, Govender N, Meiring S, Smith AM, Schrag S, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). Lancet; 2008 Mar 29; 371(9618):1108-13. PubMed ID: 18359074 [Abstract] [Full Text] [Related]
6. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Fuller JD, Low DE. Clin Infect Dis; 2005 Jul 01; 41(1):118-21. PubMed ID: 15937772 [Abstract] [Full Text] [Related]
7. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease. Pérez-Trallero E, Marimón JM, González A, Ercibengoa M, Larruskain J. Clin Infect Dis; 2005 Aug 15; 41(4):560-4. PubMed ID: 16028169 [Abstract] [Full Text] [Related]
8. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Fogarty C, Goldschmidt R, Bush K. Clin Infect Dis; 2000 Aug 15; 31(2):613-5. PubMed ID: 10987733 [Abstract] [Full Text] [Related]
9. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan. Hsieh YC, Chang LY, Huang YC, Lin HC, Huang LM, Hsueh PR. Clin Microbiol Infect; 2010 Jul 15; 16(7):973-8. PubMed ID: 19778298 [Abstract] [Full Text] [Related]
10. Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin. Pallecchi L, Riccobono E, Montagnani F, Di Maggio T, Mantengoli E, Pollini S, Rossolini GM. J Chemother; 2011 Oct 15; 23(5):308-9. PubMed ID: 22005066 [No Abstract] [Full Text] [Related]
11. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP. Antimicrob Agents Chemother; 2004 Sep 15; 48(9):3491-7. PubMed ID: 15328116 [Abstract] [Full Text] [Related]
12. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2001 Sep 21; 50(37):800-4. PubMed ID: 11785571 [Abstract] [Full Text] [Related]
13. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Nuermberger EL, Bishai WR. Clin Infect Dis; 2004 May 15; 38 Suppl 4():S363-71. PubMed ID: 15127371 [Abstract] [Full Text] [Related]
15. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, de Diego C, Gomez-Bertomeu F, Raga-Luria X, Cliville-Guasch X, Arija V. BMC Infect Dis; 2009 Mar 25; 9():36. PubMed ID: 19320989 [Abstract] [Full Text] [Related]
16. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville. Iraurgui P, Torres MJ, Aznar J. Enferm Infecc Microbiol Clin; 2012 Apr 25; 30(4):180-3. PubMed ID: 22365183 [Abstract] [Full Text] [Related]
17. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. Ross JJ, Worthington MG, Gorbach SL. N Engl J Med; 2002 Jul 04; 347(1):65-7; author reply 65-7. PubMed ID: 12097545 [No Abstract] [Full Text] [Related]
19. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema]. Carlavilla AB, López-Medrano F, Chaves F, Villena V, Echave-Sustaeta J, Aguado JM. Enferm Infecc Microbiol Clin; 2005 May 04; 23(5):270-3. PubMed ID: 15899177 [Abstract] [Full Text] [Related]
20. Efficacy of vancomycin plus levofloxacin combination therapy for refractory pericarditis due to multiresistant Streptococcus pneumoniae. Safdar A. Int J Infect Dis; 2003 Dec 04; 7(4):287. PubMed ID: 14656421 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]